The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Top Cited Papers
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 67 (3) , 351-368
- https://doi.org/10.2165/00003495-200767030-00003
Abstract
Pseudomonas aeruginosa is an important bacterial pathogen, particularly as a cause of infections in hospitalised patients, immunocompromised hosts and patients with cystic fibrosis. Surveillance of nosocomial P. aeruginosa infections has revealed trends of increasing antimicrobial resistance, including carbapenem resistance and multidrug resistance. Mechanisms of antimicrobial resistance include multidrug efflux pumps, β-lactamases and downregulation of outer membrane porins. Mechanisms of virulence include secreted toxins and the ability to form biofilms. The effective treatment of infections caused by P. aeruginosa includes prevention when possible, source control measures as necessary and prompt administration of appropriate antibacterial agents. Antibacterial de-escalation should be pursued in patients with an appropriate clinical response, especially when antibacterial susceptibilities are known. Multidrug-resistant P. aeruginosa may require treatment with less commonly used antibacterials (e.g. colistin), but newer anti-pseudomonal antibacterials are expected to be available in the near future.Keywords
This publication has 138 references indexed in Scilit:
- Use of International Units When Dosing Colistin Will Help Decrease Confusion Related to Various Formulations of the Drug around the WorldAntimicrobial Agents and Chemotherapy, 2006
- Metallo-β-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: Continued prevalence of VIM-producing pseudomonas spp. and increase of IMP-producing Acinetobacter sppDiagnostic Microbiology and Infectious Disease, 2004
- A prospective study of hospital-acquired infections in burn patients at a tertiary care referral centre in North IndiaBurns, 2004
- Catheter-Associated InfectionsArchives of internal medicine (1960), 2004
- Changes of microbial flora and wound colonization in burned patientsBurns, 2004
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- Changes in the Incidence and Etiological Patterns of Bacteremia Associated with Acute Leukemia over a 25-Year Period.Internal Medicine, 1998
- Mechanisms of resistance to β-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993Journal of Medical Microbiology, 1995
- Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosisThe Journal of Pediatrics, 1987
- Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled studyThe Journal of Pediatrics, 1984